Clinical Trials Arena March 27, 2024
GlobalData

CROs are fundamental to the development of cancer treatments but face multiple challenges. We analyze the biggest trends in oncology and the technological solutions available to CROs to optimize efficiencies.

Oncology is the most active area in clinical trials globally this year, as more resources than ever are being dedicated to developing and testing new cancer treatments. At the same time, there is the recurring issue of patient recruitment and retention, which has become heightened due to the complexities involved with oncology clinical trials. All the more reason why, coming out of the global pandemic, contract research organizations (CROs) must optimize resources, manage supply chain disruption, and leverage technology solutions to help simplify that complexity and optimize workflows.

“Oncology trials...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition
Head-to-head, it's AbbVie's Rinvoq over Regeneron's Dupixent
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Parexel strikes deal with Palantir for clinical trial AI
Risklick debuts new AI software that writes clinical trial protocols

Share This Article